Trademark Overview
On Monday, July 29, 2024, a trademark application was filed for STEMPRUVI with the United States Patent and Trademark Office. The USPTO has given the STEMPRUVI trademark a serial number of 79404070. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 12, 2024. This trademark is owned by SCM Lifescience, Inc.. The STEMPRUVI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations for the treatment of inflammatory diseases; drugs for medical purposes; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; stem cells; pharmaceutical preparations for treating epidermal problems; antibacterial pharmaceuticals.